448 related articles for article (PubMed ID: 28115842)
1. Serum CCL-18 level is a risk factor for COPD exacerbations requiring hospitalization.
Dilektasli AG; Demirdogen Cetinoglu E; Uzaslan E; Budak F; Coskun F; Ursavas A; Ercan I; Ege E
Int J Chron Obstruct Pulmon Dis; 2017; 12():199-208. PubMed ID: 28115842
[TBL] [Abstract][Full Text] [Related]
2. Clinical and Functional Lung Parameters Associated With Frequent Exacerbator Phenotype in Subjects With Severe COPD.
Capozzolo A; Carratù P; Dragonieri S; Falcone VA; Quaranta VN; Liotino V; D'Alba G; Castellana G; Resta O
Respir Care; 2017 May; 62(5):572-578. PubMed ID: 28270543
[TBL] [Abstract][Full Text] [Related]
3. The usefulness of soluble receptor for advanced glycation end-products in the identification of COPD frequent exacerbator phenotype.
Miłkowska-Dymanowska J; Białas AJ; Szewczyk K; Kurmanowska Z; Górski P; Piotrowski WJ
Int J Chron Obstruct Pulmon Dis; 2018; 13():3879-3884. PubMed ID: 30568439
[TBL] [Abstract][Full Text] [Related]
4. Association between serum CCL-18 and IL-23 concentrations and disease progression of chronic obstructive pulmonary disease.
Rong B; Fu T; Rong C; Liu W; Li K; Liu H
Sci Rep; 2020 Oct; 10(1):17756. PubMed ID: 33082377
[TBL] [Abstract][Full Text] [Related]
5. Serum PARC/CCL-18 concentrations and health outcomes in chronic obstructive pulmonary disease.
Sin DD; Miller BE; Duvoix A; Man SF; Zhang X; Silverman EK; Connett JE; Anthonisen NA; Wise RA; Tashkin D; Celli BR; Edwards LD; Locantore N; Macnee W; Tal-Singer R; Lomas DA;
Am J Respir Crit Care Med; 2011 May; 183(9):1187-92. PubMed ID: 21216880
[TBL] [Abstract][Full Text] [Related]
6. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C
Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820
[TBL] [Abstract][Full Text] [Related]
7. "Frequent exacerbator" is a phenotype of poor prognosis in Japanese patients with chronic obstructive pulmonary disease.
Tomioka R; Kawayama T; Suetomo M; Kinoshita T; Tokunaga Y; Imaoka H; Matsunaga K; Okamoto M; Hoshino T
Int J Chron Obstruct Pulmon Dis; 2016; 11():207-16. PubMed ID: 26893552
[TBL] [Abstract][Full Text] [Related]
8. Stability of the frequent COPD exacerbator in the general population: A Danish nationwide register-based study.
Reilev M; Lykkegaard J; Halling A; Vestbo J; Søndergaard J; Pottegård A
NPJ Prim Care Respir Med; 2017 Apr; 27(1):25. PubMed ID: 28416794
[TBL] [Abstract][Full Text] [Related]
9. Is serum iron responsive protein-2 level associated with pulmonary functions and frequent exacerbator phenotype in COPD?
Acet Öztürk NA; Görek Dilektaşlı A; Demirdöğen E; Coşkun F; Ursavaş A; Karadağ M; Kunt Uzaslan E
Tuberk Toraks; 2020 Sep; 68(3):252-259. PubMed ID: 33295723
[TBL] [Abstract][Full Text] [Related]
10. Stability of Frequent Exacerbator Phenotype in Patients with Chronic Obstructive Pulmonary Disease.
Krachunov I; Kyuchukov N; Ivanova Z; Yanev NA; Hristova PA; Pavlov P; Glogovska P; Popova T; Ivanov YY
Folia Med (Plovdiv); 2018 Dec; 60(4):536-545. PubMed ID: 31188775
[TBL] [Abstract][Full Text] [Related]
11. Airway IL-1β and Systemic Inflammation as Predictors of Future Exacerbation Risk in Asthma and COPD.
Fu JJ; McDonald VM; Baines KJ; Gibson PG
Chest; 2015 Sep; 148(3):618-629. PubMed ID: 25950204
[TBL] [Abstract][Full Text] [Related]
12. Predictors of Hospitalized Exacerbations and Mortality in Chronic Obstructive Pulmonary Disease.
Santibáñez M; Garrastazu R; Ruiz-Nuñez M; Helguera JM; Arenal S; Bonnardeux C; León C; García-Rivero JL
PLoS One; 2016; 11(6):e0158727. PubMed ID: 27362765
[TBL] [Abstract][Full Text] [Related]
13. The chronic obstructive pulmonary disease assessment test improves the predictive value of previous exacerbations for poor outcomes in COPD.
Miravitlles M; García-Sidro P; Fernández-Nistal A; Buendía MJ; Espinosa de Los Monteros MJ; Esquinas C; Molina J
Int J Chron Obstruct Pulmon Dis; 2015; 10():2571-9. PubMed ID: 26664105
[TBL] [Abstract][Full Text] [Related]
14. The association of tidal EFL with exercise performance, exacerbations, and death in COPD.
Aarli BB; Calverley PM; Jensen RL; Dellacà R; Eagan TM; Bakke PS; Hardie JA
Int J Chron Obstruct Pulmon Dis; 2017; 12():2179-2188. PubMed ID: 28794622
[TBL] [Abstract][Full Text] [Related]
15. Physical activity and the frequency of acute exacerbations in patients with chronic obstructive pulmonary disease.
Schönmann M; Sievi NA; Clarenbach CF; Brack T; Brutsche M; Frey M; Irani S; Leuppi JD; Ruediger J; Senn O; Thurnheer R; Kohler M
Lung; 2015 Feb; 193(1):63-70. PubMed ID: 25503750
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
[TBL] [Abstract][Full Text] [Related]
17. Statin Use and the Risk of Subsequent Hospitalized Exacerbations in COPD Patients with Frequent Exacerbations.
Lin CM; Yang TM; Yang YH; Tsai YH; Lee CP; Chen PC; Chen WC; Hsieh MJ
Int J Chron Obstruct Pulmon Dis; 2020; 15():289-299. PubMed ID: 32103928
[TBL] [Abstract][Full Text] [Related]
18. Serum periostin in patients hospitalized for COPD exacerbations.
Konstantelou E; Papaioannou AI; Loukides S; Bartziokas K; Papaporfyriou A; Papatheodorou G; Bakakos P; Papiris S; Koulouris N; Kostikas K
Cytokine; 2017 May; 93():51-56. PubMed ID: 28511944
[TBL] [Abstract][Full Text] [Related]
19. COPD Exacerbator Phenotype is Inversely Associated with Current Smoking But Not with Haptoglobin Phenotype.
Tal S; Adir Y; Stein N; Shalom H; Lache O; Levy A; Shteinberg M
Isr Med Assoc J; 2019 Jan; 21(1):19-23. PubMed ID: 30685900
[TBL] [Abstract][Full Text] [Related]
20. Characterisation of the frequent exacerbator phenotype in COPD patients in a large UK primary care population.
McGarvey L; Lee AJ; Roberts J; Gruffydd-Jones K; McKnight E; Haughney J
Respir Med; 2015 Feb; 109(2):228-37. PubMed ID: 25613107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
